Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary ... of unique prescribers, new patient prescriptions, refill ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward ...

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...

2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD: Inhalation ...

Scotland has the highest rate of drugs deaths in Europe, with fatalities rising by 12% in a year to 1,172 drug-related deaths ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

It is the most advanced mode of drug administration in which the ... adoption of homecare respiratory therapy, opening new avenues for market expansion. Despite the optimistic growth trajectory, the ...